GWENDOLYN SCOTT: Open Payments
NPI 1700331311 · QUINCY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 24 payments from 8 companies in 2025. Trend: 2023 $125 · 2024 $52 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $182 |
| Axsome Therapeutics, Inc. | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 2 | $31 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: LYBALVI, ARISTADA, Auvelity, ABILIFY ASIMTUFII, UZEDY, VRAYLAR, SPRAVATO, INVEGA SUSTENNA.
Industry payments across IL — which companies pay providers there.
